Xenon Pharmaceuticals’…
Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out [...]
Shanghai-based Tenacia…
Shanghai-based Tenacia Biotechnology is making a $308 million biobucks move [...]
After a tumultuous tenure marked…
After a tumultuous tenure marked by recent clashes with the [...]
The FDA is ending a roughly…
The FDA is ending a roughly nine-month hiatus of drug-related [...]
The planned closure of Bio Palette…
The planned closure of Bio Palette has triggered the termination [...]
After 27 years with Bavarian…
After 27 years with Bavarian Nordic, including 12 as CEO, [...]
Zealand Pharma’s Roche-partnered…
Zealand Pharma’s Roche-partnered amylin analog demonstrated “placebo-like tolerability” and up [...]
In a strikingly blunt briefing, a…
In a strikingly blunt briefing, a senior FDA official accused [...]
Merck KGaA is no longer pursuing…
Merck KGaA is no longer pursuing clinical-stage candidates obtained through [...]
Flagship Pioneering-backed Alltrna…
Flagship Pioneering-backed Alltrna is once again laying off staff, this [...]